LEADER 01645nam  2200421Ia 450 
001 9910695978603321
005 20070717072114.0
035   $a(CKB)5470000002374012
035   $a(OCoLC)156152990
035   $a(EXLCZ)995470000002374012
100   $a20070717d2007      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMedicare Part D$b[electronic resource] $eenrolling new dual-eligible beneficiaries in prescription drug plans : testimony before the Committee on Finance, U.S. Senate /$fstatement of Kathleen M. King
210  1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2007]
215   $a11 pages $cdigital, PDF file
225 1 $aTestimony ;$vGAO-07-824 T
300   $aTitle from title screen (viewed on July 3, 2007).
300   $a"For release ... May 8, 2007."
300   $aPaper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.
320   $aIncludes bibliographical references.
517   $aMedicare Part D 
606   $aMedicare beneficiaries
606   $aOlder people$xPharmaceutical assistance$zUnited States
615  0$aMedicare beneficiaries.
615  0$aOlder people$xPharmaceutical assistance
700   $aKing$b Kathleen M$01383406
712 02$aUnited States.$bCongress.$bSenate.$bCommittee on Finance.
712 02$aUnited States.$bGovernment Accountability Office.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910695978603321
996   $aMedicare Part D$93500132
997   $aUNINA